venBio Global Strategic Fund II L.P. 4
4 · Akero Therapeutics, Inc. · Filed Jan 14, 2020
Insider Transaction Report
Form 4
venBio Global Strategic Fund II L.P.
10% Owner
Transactions
- Sale
Common Stock
2020-01-13$20.23/sh−494,000$9,993,620→ 3,322,138 total(indirect: See footnote)
Footnotes (1)
- [F1]These shares are held by venBio Global Strategic Fund II, L.P. venBio Global Strategic GP II, LP is the sole general partner of venBio Global Strategic Fund II, LP and venBio Global Strategic GP II, Ltd. is the sole general partner of venBio Global Strategic GP II, L.P. Robert Adelman and Corey Goodman are directors of venBio Global Strategic GP II, Ltd. Each of venBio Global Strategic GP II, L.P., venBio Global Strategic GP II, Ltd., Mr. Adelman and Mr. Goodman disclaims beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein.